Vistagen Therapeutics, Inc. (VTGN) earnings
Quarterly results of Vistagen Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Vistagen Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q1 FY2027
In Q1 FY2027 (ended June 30, 2026) Vistagen Therapeutics, Inc. reported revenue of $1.5M (+504.9% on the same quarter a year earlier) and a net loss of $13M.
Diluted earnings per share were -$0.30.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q1 FY2027 | $1.5M | +504.9% | -$13M | -$0.30 |
| Q4 FY2026 | $464K | - | -$16.3M | - |
| Q3 FY2026 | $303K | +29.5% | -$18.9M | -$0.45 |
| Q2 FY2026 | $258K | +41% | -$19.4M | -$0.54 |
| Q1 FY2026 | $244K | - | -$15.1M | -$0.47 |
| Q4 FY2025 | -$15K | - | -$13.6M | - |
| Q3 FY2025 | $234K | - | -$14.1M | -$0.46 |
| Q2 FY2025 | $183K | - | -$13M | -$0.42 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
When is Vistagen Therapeutics, Inc.'s next earnings date?
Vistagen Therapeutics, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Vistagen Therapeutics, Inc.'s latest quarterly results?
For Q1 FY2027, which ended June 30, 2026, Vistagen Therapeutics, Inc. reported revenue of $1.5M and a net loss of $13M. The figures come from its filing with the SEC.
Is Vistagen Therapeutics, Inc.'s revenue growing?
Revenue in Q1 FY2027 was $1.5M, up 504.9% from $244K in the same quarter a year earlier.
Get an email when VTGN reports
Follow VTGN and we email you its next results the day they are filed, with the numbers explained.